Introduction
Chronic kidney disease (CKD) is an important public health issue, affecting an estimated 13% to 16% of the U.S. population and accounting for nearly 28% of Medicare spending in 2007 (1) . Although CKD risk factors such as poorly controlled diabetes and hypertension are well established, efforts to reduce these risk factors alone have not yet resulted in a decrease in the prevalence of CKD (2) . Therefore, identifying and treating nontraditional modifiable risk factors for CKD could have a tremendous effect on the societal burden of CKD.
Periodontal disease, a chronic bacterial infection of the oral cavity, may be such a risk factor. Periodontal pathogens have been shown to have the ability to adhere to, invade, and proliferate in coronary endothelial cells (3, 4) , leading to atheroma formation (5, 6) and impaired vasculature relaxation (7) . Because cardiovascular disease and CKD share many risk factors, it is biologically plausible that periodontal disease exerts similar effects within the vasculature of the kidney.
Recent studies have shown an association between periodontal disease and CKD, with periodontal disease being associated with a 1.6-to 2.0-fold greater risk of CKD (8 -10) . Importantly, periodontal disease disproportionately affects nonwhites, those with low income, and those with a lower educational level (11) (12) (13) . For example, in a nationally representative sample, Borrell et al. (13) found that the prevalence of periodontal disease among non-Hispanic blacks was more than twice that of non-Hispanic whites (7.2% versus 3.0%), and the risk of periodontal disease was 2-fold greater among non-Hispanic blacks, those with low income, and those with less than a high school education. Furthermore, higher age-adjusted incidence rates of CKD (14 -17) and faster progression to end-stage renal disease (18 -24) among nonwhites and the poor have also been observed. Because periodontal disease and CKD are associated with racial/ethnic and social disparities, we hypothesized that any CKD risk associated with periodontal disease might vary among these subgroups. Therefore, we sought to characterize the association of periodontal disease and CKD among race/ ethnicity, educational attainment, and poverty status subgroups within a nationally representative sample of adults.
Materials and Methods

Study Population
The population for this study was drawn from the National Health and Nutrition Examination Survey (NHANES). NHANES is a well established representative survey of noninstitutionalized civilian residents in the United States conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention. The survey consists of a standardized in-home interview followed by a physical examination and blood and urine collection at a mobile examination center. All participants give written informed consent. The protocol was approved by the National Center for Health Statistics Research Ethics Review Board.
Our study was limited to dentate non-Hispanic white, non-Hispanic black, or Mexican-American participants aged 21 to 75 years from 2001 to 2004 with detailed periodontal exams. NHANES did not include periodontal examinations after 2004. Participants missing dental or kidney function measures were excluded. Participants who were edentulous or pregnant were excluded.
Measurements
Study-trained dentists conducted the periodontal examinations (25, 26) . Clinical attachment loss and pocket probe depths were recorded midbuccal, mesiobuccal, and distobuccal for each tooth. In the oral health questionnaire, participants were asked about their last dental visit ("About how long has it been since you last visited the dentist? Include all types of dentists, such as orthodontics, oral surgeons, and all other dental specialists, as well as dental hygienists.") and reason for last dental visit ("What was the main reason you last visited the dentist?").
Serum creatinine concentration was measured by the modified kinetic method of Jaffe using different analyzers in different survey years. Creatinine levels were corrected as specified in NHANES documentation (27, 28) and were used in formulas for estimates of kidney function. Random spot urine samples were obtained, and urine albumin and creatinine were measured using frozen specimens. Urine albumin was measured using solid-phase fluorescence immunoassay. Urine creatinine was measured using the modified Jaffe kinetic method in the same laboratory.
Definitions
We defined periodontal disease as a dichotomous variable: none/mild or moderate/severe disease. In accordance with the Centers for Disease Control and Prevention/American Academy of Periodontology (CDC/AAP) definition, participants were considered to have moderate/severe disease if there were two or more interproximal tooth sites not on the same tooth with a level of attachment of Ն4 mm or pocket probe depths Ն5 mm. This definition was developed in an effort to standardize the clinical case definition of periodontal disease for population-based studies (29) . We created a composite variable for dental care use from self-reported last dental visit and reason for last dental visit. Dental care use was defined as "as recommended" if the last dental visit was reported Ͻ1 year prior and for a routine reason (went in on own or was called in by dentist for check-up, examination, or cleaning). Dental care use was considered "less than recommended" if the last dental visit was Ͼ1 year ago, for a problem (something was wrong, bothering, or hurting or went for treatment of a condition that a dentist discovered at an earlier check-up or examination), or for another reason.
We defined CKD as the presence of reduced kidney function (estimated GFR [eGFR] 15 to 59 ml/min per 1.73 m 2 ) and/or albuminuria (urinary albumin-to-creatinine ratio Ն 30 mg/g). eGFR was calculated according to the Modification of Diet in Renal Disease study equation for calibrated creatinine: eGFR ϭ 175 ϫ [(calibrated serum creatinine in mg/ dl)
We categorized self-reported age into four groups (21 to 34, 35 to 49, 50 to 64, and 65 to 75 years) and selfreported race/ethnicity as non-Hispanic white, non-Hispanic black, or Mexican American. Self-reported significant tobacco use (none, past, ongoing) included cigarettes, snuff, and chewing tobacco. Lifetime use of Ͼ100 cigarettes or 20 units of snuff or chewing tobacco was considered significant use. Body mass index (in kg/m 2 ) was calculated using height and weight measured during the exam. BP (at least three auscultatory measurements) was measured during the exam. Hypertension was defined as the participant reporting having ever been told by a healthcare provider that they had hypertension or by the finding of an average of second and third readings of BP Ն140 mmHg systolic or Ն90 mmHg diastolic. We defined diabetes as the participant reporting being told by a provider that they had diabetes or by the conservative finding of a glycosylated hemoglobin Ͼ8% to minimize misclassification due to participant unawareness of diabetes diagnosis. Educational attainment was categorized as more than high school, high school or high school equivalent, and less than high school. We defined poverty status using the U.S. Census Bureau's poverty index ratio, the ratio of family income to federal poverty level: Յ1.00 is considered below the poverty level. We defined poverty status as a three-level variable: poverty index ratio Յ1.00, 1.01 to 3.49, or Ն3.50.
Statistical Analyses
We compared participant characteristics for periodontal disease categories using 2 analyses. We used multivariable logistic regression to assess the presence, direction, strength, and independence of the association between periodontal disease and CKD. Covariates were added to the unadjusted regression model in a stepwise fashion if they were associated (P Ͻ 0.05) with periodontal disease and CKD in our sample population (i.e., true confounders). Next, we tested for interactions between periodontal disease and race/ethnicity, poverty status, or educational attainment within the fully adjusted model. Finally we described self-reported dental use among race/ethnicity, educational attainment, and poverty status subgroups and tested for the association of dental use with periodontal disease.
We repeated analyses with CKD defined by GFR estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (31) . Finally, we conducted sensitivity analyses with periodontal disease as defined by other authors examining the association of periodontal disease with CKD (8, 10) . All analyses were performed using the svy commands in Stata v. 11.0 (College Station, TX) to account for study design weights, strata, and primary sampling units.
Results
We included 6199 dentate, adult (age 21 to 75 years) participants from NHANES 2001 to 2004 who met our study criteria. From a total denominator of 21,161 participants who were non-Hispanic white, non-Hispanic black, or Mexican American, we excluded 12,236 participants under the age of 21 years, 618 pregnant participants, 1613 missing kidney function measures, and 495 missing dental measures. The overall estimated prevalences of moderate/ severe periodontal disease and CKD were 5.3% and 10.6%, respectively. Being older, male, nonwhite, less educated, and poor were all associated with moderate/severe versus no/mild periodontal disease (Table 1) . Ongoing or past Total percent category by characteristic may exceed 100% because of rounding. CKD, chronic kidney disease (eGFR15 to 59 ml/ min per 1.73m 2 or urine albumin-to-creatnine ratio Յ 30 mg/g).
tobacco use, diabetes, and hypertension were more common among participants with moderate/severe versus no/ mild periodontal disease. Recommended dental care was less frequently reported among participants with moderate/severe versus no/mild periodontal disease. In unadjusted logistic regression models, the odds of participants with moderate/severe periodontal disease having CKD were more than twice that of those with no/mild periodontal disease ( Table 2 ). The strength of the association was modestly attenuated but remained statistically significant after adjustment for age, gender, tobacco use, diabetes, and hypertension. There was further attenuation after adjusting for race/ethnicity, educational attainment, poverty status, and dental care use, but the association remained statistically significant. Although stratified analyses by race/ethnicity, poverty status, or educational attainment revealed some significant associations, tests for interaction were NS (Table 3) .
Fewer than half of the participants reported receiving recommended dental care. Non-Hispanic blacks and Mexican Americans less frequently reported recommended dental care use than non-Hispanic whites (Figure 1 ). Those with lower educational attainment and lower poverty status less frequently reported receipt of recommended dental care. Those reporting less-than-recommended dental care use were twice as likely to have moderate/severe periodontal disease than those reporting recommended dental care use after adjustment for other covariates (odds ratio [OR] 1.99, 1.37 to 2.89, P ϭ 0.001).
In separate analyses using the CKD-EPI equation to define CKD, 9.2% of the population had CKD. Of participants with no/mild periodontal disease, 8.6% had CKD whereas 20.5% of those with moderate/severe periodontal disease had CKD. The overall association between periodontal disease and CKD was stronger than that using the Modification of Diet in Renal Disease equation (unadjusted OR 2.73, 2.23 to 3.35, P Ͻ 0.001) and was modestly attenuated after adjusting for age and gender (OR 1.91, 1.49 to 2.45, P Ͻ 0.001); after additionally adjusting for tobacco use, diabetes, and hypertension (OR 1.75, 1.35 to 2.26, P Ͻ 0.001); after additionally adjusting for race/ethnicity, poverty status, and educational attainment (OR 1.63, 1.22 to 2.16, P ϭ 0.001); and lastly, after additionally adjusting for dental care use (OR 1.59, 1.19 to 2.11, P ϭ 0.002). There were no significant interactions between periodontal disease and race/ ethnicity, poverty status, or educational attainment for the association with CKD (data not shown).
Our sensitivity analysis using Kshirsagar and colleagues' (8) case definition for periodontal disease (two or more interproximal sites on different teeth with Ն4 mm or clinical attachment level) yielded nearly identical results (OR 1.52, 1.13 to 2.04, P ϭ 0.008 in the fully adjusted model). In our sensitivity analysis using Fisher and colleagues' (10) case definition, which requires the presence of bleeding on probing with the periodontal examination (an indicator of active inflammation) on the same one or more sites with loss of attachment of Ն4 mm, periodontal disease was associated with CKD in the unadjusted model (OR 2.00, 1.45 to 2.75, P Ͻ 0.001). This association was attenuated with adjustment for comorbidities (OR 1.42, 0.99 to 2.04, P ϭ 0.056).
Discussion
In a recent nationally representative sample of U.S. adults, we observed a significant association between periodontal disease and CKD. This association was attenuated but remained statistically significant after adjustment for confounders. Consistent with prior nation- ally representative (11, 13) and cohort (12) studies, we found that periodontal disease disproportionately affects nonwhites, those with low income, and those with a lower educational level. Therefore, we postulated that the association of CKD and periodontal disease would be stronger among these subgroups. In stratified analyses, the association appeared strongest among non-Hispanic whites and the very poor, but tests for interaction of periodontal disease by subgroup and CKD were NS, arguing against a differential biologic mechanism. We do not know if the relationship was actually stronger in these groups, and our study was not sufficiently powered to detect the difference or if the observed relationship was the result of sampling variation. Alternatively, the finding among the very poor may be part of a very complex, unmeasured set of factors more common to the group (e.g., environmental exposure to specific periodontal pathogens and oral hygiene) that, taken together, may increase risk of CKD.
However, of note, the self-reported lack of recommended dental care use-as more frequently reported by nonwhites, those with a lower educational level, and the poor-was associated with periodontal disease and CKD. Although adjustment for dental care use did not fully attenuate the association between periodontal disease and CKD, this finding suggests that periodontal disease prevention or treatment may play a role in attenuating the development or progression of CKD and warrants further investigation.
Our findings are similar to those among all adults in NHANES III (1988 to 1994), in whom periodontal disease and edentulism were associated with a 1.6 and 1.9 greater risk of CKD, respectively (10). Among middleaged dentate adults in the Atherosclerosis Risk in Communities study, severe periodontal disease was associated with a 2-fold greater risk of CKD (8) . Although our results show a similar association between periodontal disease and CKD, our study further informs the field by additionally accounting for dental care use and exploring subgroup differences. Furthermore, we used the CDC/AAP definition for periodontal disease, which was developed in an effort to standardize the clinical case definition of periodontal disease for population-based studies. Our sensitivity analysis using the Kshirsagar et al. (8) definition yielded similar results, likely because of its similarity to the CDC/AAP definition. On the other hand, the results from the sensitivity analysis using the Fisher et al. (10) definition likely reflect its requirement of active inflammation, which may reflect earlier periodontal disease that has yet to impair kidney function independent of comorbid conditions.
The biologic plausibility of periodontal disease leading to impaired kidney function through endothelial injury is supported by an extensive cardiovascular literature. Interestingly, treatment of periodontal disease has recently been shown to positively affect a surrogate marker for clinical cardiovascular disease through sustained increases in brachial artery dilation and blood flow (32) . Given that epidemiologic studies have demonstrated an overall association between periodontal disease and cardiovascular disease (33) similar in direction and magnitude to that found between periodontal disease and CKD, it is important to explore to what extent treatment of periodontal disease may affect kidney function.
A limitation of our cross-sectional study is that we did not have data on persistent albuminuria. Because we included albuminuria in our definition of CKD, we may have overestimated the prevalence of CKD. On the other hand, because NHANES periodontal examinations included only three tooth sites (rather than a full six-site examination), we likely also underestimated the prevalence of periodontal disease. Another limitation is that our measure of dental care use is based on participant recall and is therefore subject to recall and social desirability bias. Furthermore, even if reported accurately, the last year may not be typical of an individual's usual pattern of accessing dental care. This may have skewed our analyses against estimating the true effect of recommended dental care use. Additionally, all observational studies are subject to possible confounding due to unknown or unmeasured factors. Finally, cross-sectional studies such as this do not allow for causal inference, and reverse causation (CKD causing periodontal disease), or the coexistence of the two due to common underlying risk factors, cannot be excluded.
In summary, the association between periodontal disease and CKD is not significantly different among subgroups. However, because less-than-recommended dental care use is strongly associated with periodontal disease and is most common among nonwhites, those with a lower educational level, and the poor, the effect of periodontal disease over time may be more profound among these groups. Longitudinal studies are needed to determine to what extent periodontal disease is a true risk factor for CKD and to what extent periodontal disease treatment affects the trajectory of kidney function over time.
